Prime Therapeutics Is Acquiring Magellan Rx To Advance Integrated Specialty Drug Management, Accelerating Efforts To Lower The Cost Of Drugs And Improve Health Outcomes
May 05, 2022•over 3 years ago
Acquiring Company
Prime Therapeutics
Acquired Company
Magellan Rx
Description
Pharmacy benefit manager Prime Therapeutics LLC (Prime) on May 3 entered into a definitive agreement with Centene Corporation to acquire Magellan Health, Inc.'s pharmacy business, Magellan Rx Management, (Magellan Rx) for approximately $1.35 billion.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed